Vaccinex Stock Z Score
| VCNX Stock | USD 5.83 0.10 1.69% |
Vaccinex | Z Score |
Vaccinex Company Z Score Analysis
Vaccinex's Z-Score is a simple linear, multi-factor model that measures the financial health and economic stability of a company. The score is used to predict the probability of a firm going into bankruptcy within next 24 months or two fiscal years from the day stated on the accounting statements used to calculate it. The model uses five fundamental business ratios that are weighted according to algorithm of Professor Edward Altman who developed it in the late 1960s at New York University..
| |||||||
| |||||||
| |||||||
| |||||||
|
Vaccinex Z Score Driver Correlations
Understanding the fundamental principles of building solid financial models for Vaccinex is extremely important. It helps to project a fair market value of Vaccinex Stock properly, considering its historical fundamentals such as Z Score. Since Vaccinex's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Vaccinex's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Vaccinex's interrelated accounts and indicators.
Click cells to compare fundamentals
To calculate a Z-Score, one would need to know a company's current working capital, its total assets and liabilities, and the amount of its latest earnings as well as earnings before interest and tax. Z-Scores can be used to compare the odds of bankruptcy of companies in a similar line of business or firms operating in the same industry. Companies with Z-Scores above 3.1 are generally considered to be stable and healthy with a low probability of bankruptcy. Scores that fall between 1.8 and 3.1 lie in a so-called 'grey area,' with scores of less than 1 indicating the highest probability of distress. Z Score is a used widely measure by financial auditors, accountants, money managers, loan processors, wealth advisers, and day traders. In the last 25 years, many financial models that utilize z-scores proved it to be successful as a predictor of corporate bankruptcy.
| Competition |
As per the company's disclosures, Vaccinex has a Z Score of 0.0. This is 100.0% lower than that of the Biotechnology sector and 100.0% lower than that of the Health Care industry. The z score for all United States stocks is 100.0% higher than that of the company.
Vaccinex Z Score Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Vaccinex's direct or indirect competition against its Z Score to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Vaccinex could also be used in its relative valuation, which is a method of valuing Vaccinex by comparing valuation metrics of similar companies.Vaccinex is currently under evaluation in z score category among related companies.
Vaccinex Current Valuation Drivers
We derive many important indicators used in calculating different scores of Vaccinex from analyzing Vaccinex's financial statements. These drivers represent accounts that assess Vaccinex's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Vaccinex's important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 175.6M | 266.5M | 30.0M | 27.4M | 4.3M | 4.1M | |
| Enterprise Value | 174.2M | 260.9M | 21.8M | 21.4M | 3.0M | 2.9M |
Vaccinex Institutional Holders
Institutional Holdings refers to the ownership stake in Vaccinex that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Vaccinex's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Vaccinex's value.| Shares | Advisor Group Holdings, Inc. | 2023-12-31 | 234 | Wells Fargo & Co | 2023-12-31 | 68.0 | Simplex Trading, Llc | 2023-09-30 | 54.0 | Morgan Stanley - Brokerage Accounts | 2023-12-31 | 20.0 | Cornerstone Planning Group Llc | 2023-09-30 | 14.0 | Jpmorgan Chase & Co | 2023-12-31 | 10.0 | Bank Of America Corp | 2023-12-31 | 4.0 | Creative Planning Inc | 2023-09-30 | 0.0 | State Street Corporation | 2023-09-30 | 0.0 | Aigh Capital Management, Llc | 2023-12-31 | 817.1 K | Worth Venture Partners, Llc | 2023-12-31 | 654.1 K |
Vaccinex Fundamentals
| Return On Equity | -14.05 | ||||
| Return On Asset | -2.46 | ||||
| Operating Margin | (40.15) % | ||||
| Current Valuation | 5.89 M | ||||
| Shares Outstanding | 1.58 M | ||||
| Shares Owned By Insiders | 6.77 % | ||||
| Shares Owned By Institutions | 41.70 % | ||||
| Number Of Shares Shorted | 16.23 K | ||||
| Price To Book | 3.05 X | ||||
| Price To Sales | 16.95 X | ||||
| Revenue | 570 K | ||||
| Gross Profit | (13.7 M) | ||||
| EBITDA | (22.77 M) | ||||
| Net Income | (20.25 M) | ||||
| Cash And Equivalents | 11.4 M | ||||
| Cash Per Share | 0.27 X | ||||
| Total Debt | 247 K | ||||
| Debt To Equity | 0.02 % | ||||
| Current Ratio | 8.22 X | ||||
| Book Value Per Share | (2.59) X | ||||
| Cash Flow From Operations | (17.23 M) | ||||
| Short Ratio | 1.50 X | ||||
| Earnings Per Share | (43.68) X | ||||
| Target Price | 7.0 | ||||
| Number Of Employees | 37 | ||||
| Beta | 0.7 | ||||
| Market Capitalization | 9.24 M | ||||
| Total Asset | 3.63 M | ||||
| Retained Earnings | (339.93 M) | ||||
| Working Capital | (2.57 M) | ||||
| Net Asset | 3.63 M |
About Vaccinex Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Vaccinex's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Vaccinex using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Vaccinex based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Vaccinex in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Vaccinex's short interest history, or implied volatility extrapolated from Vaccinex options trading.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Vaccinex offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Vaccinex's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Vaccinex Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Vaccinex Stock:Check out Vaccinex Piotroski F Score and Vaccinex Valuation analysis. For more information on how to buy Vaccinex Stock please use our How to Invest in Vaccinex guide.You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Complementary Tools for Vaccinex Stock analysis
When running Vaccinex's price analysis, check to measure Vaccinex's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vaccinex is operating at the current time. Most of Vaccinex's value examination focuses on studying past and present price action to predict the probability of Vaccinex's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vaccinex's price. Additionally, you may evaluate how the addition of Vaccinex to your portfolios can decrease your overall portfolio volatility.
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data |
Is Vaccinex's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Vaccinex. If investors know Vaccinex will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Vaccinex listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (43.68) | Revenue Per Share 1.229 | Quarterly Revenue Growth (1.00) | Return On Assets (2.46) | Return On Equity (14.05) |
The market value of Vaccinex is measured differently than its book value, which is the value of Vaccinex that is recorded on the company's balance sheet. Investors also form their own opinion of Vaccinex's value that differs from its market value or its book value, called intrinsic value, which is Vaccinex's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Vaccinex's market value can be influenced by many factors that don't directly affect Vaccinex's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Vaccinex's value and its price as these two are different measures arrived at by different means. Investors typically determine if Vaccinex is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Vaccinex's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.